Dr. Caplan, The Commonwealth Project, and the DEA Rescheduling Proceedings: Clinical Evidence and Policy Context

Share

Regulatory & Procedural Update (November 2026)

Factual Summary: As Chief Medical Officer of The Commonwealth Project, Dr. Caplan contributed to an organization selected as one of 25 designated participants in the DEA’s original 2024–2025 marijuana rescheduling proceeding. The organization was scheduled to present its case in January 2025, before the proceedings were stayed.

Editorial Note (November 15, 2026): This post retains its original publication date of November 20, 2024. The administrative hearings originally scheduled for January 2025 did not convene as the proceedings were stayed by the DEA Administrative Law Judge, and the original hearing process was subsequently terminated before testimony was delivered. The DEA issued a new hearing notice in April 2026. Dr. Caplan continues to advise healthcare organizations and policy stakeholders on evidence-based cannabinoid science.

Dr. Benjamin Caplan, MD

Written & Medically Reviewed by Benjamin Caplan, MD

ABFM Board-Certified Family Physician | MA Medical License #257356 | NPI: 1962722637
Chief Medical Officer, The Commonwealth Project & CED Clinic | Author of The Doctor-Approved Cannabis Handbook

Dr. Benjamin Caplan has personally overseen the care of about 35,000 patients, with about 400,000 patients under management, and advises state health departments, federal policymakers, and healthcare systems on evidence-based cannabis reform. For clinical consultations or advisory inquiries, visit CED Clinic or explore The Commonwealth Project.